anthrax

Equity Research Report: Emergent Biosolutions 3Q17

Download the Report in PDF: EBS Report Download the Valuation in Excel: Emerging Biosolutions Valuation Emergent Biosolutions Inc.: 3Q17 Recommendation: BUY Target Price : $49.86 Closing Price : $40.86 Upside (Downside) Potential : 22.0% Company Profile Emergent BioSolutions Inc. develops, manufactures, and commercializes immunobiotics such as vaccines and immune globulins that assist the body’s immuneContinue reading “Equity Research Report: Emergent Biosolutions 3Q17”